Clinical Trials Browser

Phase 2 × Colonic Neoplasms × tumor necrosis factor-alpha, CNGRC fusion protein, human × Clear all

NCT00675012 2014-05-30

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms